Results 251 to 260 of about 18,729 (264)

Endothelin receptor antagonists

2003
openaire   +1 more source

Clinical Pharmacology of Bosentan, a Dual Endothelin Receptor Antagonist

Clinical Pharmacokinetics, 2004
J. Dingemanse, P. Giersbergen
semanticscholar   +1 more source

The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis

European Journal of Pharmacology, 1992
Eliot H Ohlstein, John D Elliott, C P Sung   +2 more
exaly  

Binding characterization of []S-0139, an antagonist of the endothelin ETA receptor subtype

European Journal of Pharmacology, 1998
Shin-Ichi Mihara, Masafumi Fujimoto
exaly  

Endothelin receptor antagonists

2011
openaire   +1 more source

Multiple‐Dose Pharmacokinetics, Safety, and Tolerability of Bosentan, an Endothelin Receptor Antagonist, in Healthy Male Volunteers

Journal of clinical pharmacology, 1999
C. Weber, R. Schmitt, H. Birnboeck, G. Hopfgartner, H. Eggers, Joseph Meyer, S. Marle, Henk W. Viischer, J. Jonkman   +8 more
semanticscholar   +1 more source

Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis.

Arthritis & Rheumatism, 2007
P. Sfikakis, C. Papamichael, K. Stamatelopoulos, D. Tousoulis, K. Fragiadaki, P. Katsichti, C. Stefanadis, M. Mavrikakis   +7 more
semanticscholar   +1 more source

In vivo pharmacological characterization of the non‐peptide endothelin receptor antagonist SB 209670

British Journal of Pharmacology, 1995
Stephen A Douglas, Richard M Edwards, John D Elliott   +2 more
exaly  

Pharmacology of A-216546: a highly selective antagonist for endothelin ETA receptor

European Journal of Pharmacology, 1999
Jinshyun R Wu-Wong, William J Chiou, Brian D Dayton   +2 more
exaly  

Clinical development of endothelin receptor antagonists

Trends in Pharmacological Sciences, 1997
openaire   +2 more sources